Fresenius Mabxience and Biosidus Collaborate in CDMO Agreement for Fabry Disease
Fresenius Mabxience has announced a Contract Development and Manufacturing Organisation (CDMO) agreement with Biosidus. This collaboration aims to develop a treatment for Fabry disease, a…